ALLR vs INCY · P/E 0.0, rev $25.0K vs P/E 14, rev $5.14B
Allarity Therapeutics Inc (ALLR) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the ALLR and INCY stock pages for the full models.
Not investment advice.